A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates

Journal of Perinatology

Volumn 25, Issue 5, 2005, Pages 325-330

  Murki, Srinivas ^a   Dutta, Sourabh ^a   Narang, Anil ^a   Sarkar, Urmi ^a   Garewal, Gurjeevan ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CALCIUM CARBONATE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; PHENOBARBITAL; PLACEBO; SHELCAL;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MECHANISM; ENZYME INDUCTION; EXCHANGE BLOOD TRANSFUSION; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HUMAN; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN JAUNDICE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME; TRIPLE BLIND PROCEDURE;

ADMINISTRATION, ORAL; CRITICAL CARE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; JAUNDICE, NEONATAL; MALE; PHENOBARBITAL; PHOTOTHERAPY; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 18444417425     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jp.7211258     Document Type: Article

References (24)

1. Jolly JG, Sarup BM, Bhatnagar DP, Maini SC. Glucose 6 phosphate dehydrogenase deficiency in India. J Indian Med Assoc 1972;58:196.
2. Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose 6 phosphate dehydrogenase deficient newborns using an inhibitor of bilirubin production, Sn-Mesoporphyrin. Pediatrics 1998;101: http://www.pediatrics.org/cgi/content/full/105/5/el.
3. Kaplan M, Muraca M, Hammerman C, et al. Bilirubin conjugation reflected by conjugated bilirubin fractions in glucose 6 phosphate dehydrogenase deficient neonates - a determining factor in the pathogenesis of hyperbilirubinemia. Pediatrics 1998;102: http://www.pediatrics.org/egi/content/full/102/3/e37.
4. Meloni T, Costa S, Cuuntilo S. Haptoglobin, hemopexin, hemoglobin and haematocrit in newborns with erythrocytes glucose 6 phosphate dehydrogenase deficiency. Acta Hematol 1975;54:284-8.
5. Valaes T, Karaklis A, Stavrakakis D, Bavela-Stavrakakis K, Perakis A, Doxiadis SA. Incidence and mechanism of neonatal jaundice retated to G6PD deficiency. Pediatr Res 1969;3:448-58.
6. Kaplan M, Buetller E, Vreman HJ, et al. Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient heterozygotes. Pediatr 1999;104:68-74.
7. Meloni T, Cagnazzo G, Dore A, Cuuntillo S. Phenobarbital for prevention of hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient newborn infants. J Pediatr 1973;82:1048.
8. Meloni T, Dore A, Cuuntilo S. The effect of phenobarbitone in the hyperbilirubinemia of neonates with deficiency of glucose-6-phosphate dehydrogenase of the erythrocytes. Helv Pediatr Acta 1972;274:197 [German].
9. Gall JC, Brewer GJ, Dern RJ. Studies of glucose-6-phosphate dehydrogenase activity of individual erythrocytes: the methemoglobin elution test for identification of female heterozygotes for G6PD deficiency. Am J Hum Genet. 1965;17:359.
10. Valaes TN, Harvey-Wilkes K. Pharmacologic approaches to the prevention and treatment of neonatal hyperbilirubinemia. Clin Perinatol 1990;17: 245-73.
11. National Neonatology Forum. The National Neonatal-Perinatal Database, India. Report for the Year 2000; p. 39.
12. Cockington RA. A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia. J Pediatr 1979;95:281-5.
13. American Academy of Pediatrics: Practice parameter: Management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994;94: 558-565.
14. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a pre-discharge hour specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near term newborns. Pediatrics 1999;103:6-14.
15. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci 1997;94:12128-32.
16. Iolascon A, Faienza MF, Perrotta S, Meloni GF, Ruggiu G, del Giudice EM. Gilbert's syndrome and jaundice in glucose-6-phosphate dehydrogenase deficient neonates. Haematologica 1999;84:99-102.
17. Beutler E. G6PD deficiency. Blood 1994;84:3613-36.
18. Mohanty D, Mukherjee MB, Colah RB. Glucose-6-phosphate dehydrogenase deficiency in India. Indian J Pediatr 2004;71:525-9.
19. Kaplan M, Algur N, Hammerman C. Onset of jaundice in glucose 6 phosphate dehydrogenase deficient neonates. Pediatrics 2001;108:956-9.
20. Kumar R, Narang A, Kumar P, Garewal G. Study of postnatal phenobarbitone prophylaxis for neonatal jaundice in babies with birth weight 1000-1499 grams. Indian Pediatr 2002;39:945-51.
21. Cuuntilo S, Meloni T, Dore A. Effect of orotic acid upon serum bilirubin in newborn infants with erythrocyte G6PD deficiency. Acta Paediatr Scand 1974;63:143-6.
22. Kappas A, Drummond GS, Valaes T. A single dose of Sn-Mesoporphyrin prevents development of severe hyperbilirubinemia in glucose-6-phosphate dehydrogenase deficient newborns. Pediatrics 2001;108:25-30.
23. Meloni T, Forteleoni G, Dore A, Cutillo S. Neonatal hyperbilirubinemia in heterozygous glucose-6-phosphate dehydrogenase deficient females. Br J Haematol 1983;53:241-6.
24. Weng YH, Chou YH, Lien RI. Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency. Early Hum Dev 2003;71:129-36.